Hormone Myths vs. Longevity Realities Part 2

A single scary headline from 2002 changed women’s health care for a generation and we’re still paying for it. We dig into why “hormone therapy is dangerous” became the default narrative, what the Women’s Health Initiative (WHI) actually studied, and how the real clinical picture depends on timing, formulation, and delivery method. We talk through the timing hypothesis or “window of opportunity,” why transdermal estradiol differs from oral estrogen for clot risk, and why bioidentical progesterone is not the same thing as synthetic progestins when you’re weighing safety and tolerability. 

Then we shift to the myth that you’ll automatically know when perimenopause starts. Many women wait for hot flashes, but early perimenopause symptoms often look like new anxiety, 2–4 a.m. waking, brain fog, mood shifts, joint aches, and workouts that suddenly take days to recover from. We also explain why a normal FSH or estradiol on one blood draw doesn’t rule anything out early on because hormones fluctuate and symptoms plus history often matter more than a single lab. 

We close with two mindset resets that protect your healthspan: menopause is not a finish line, and lifestyle is not always sufficient when insulin sensitivity, sleep architecture, muscle protein synthesis, thyroid function, and cortisol rhythms shift. If you’ve been doing “everything right” and still feel off, you deserve an individualized clinical evaluation and an honest risk-benefit conversation. Subscribe for more evidence-based women’s health, share this with a friend who needs better answers, and leave a review so more women can find the show.

Start Here: Take the Healthspan Baseline quiz. About three minutes, covering energy, brain fog, mood, sleep, and long-term health patterns. You'll see where to focus and receive a one-page guide: 👉 https://rootremedyic.involve.me/next-decades-healthspan-quiz

Personalized Care: I work with women in AZ, CO, FL, ID, KY, MT, OR, WA, and WY through Root & Remedy Integrative Care. We start with a Health Consultation, then I select labs based on your symptom pattern and send you a written Next Steps Plan within 72 hours: 👉 https://www.rootremedyic.com/work-with-me

Courses & Digital Guides: Not in a state I serve? Browse self-paced courses and clinically written guides on hormones, energy, sleep, cortisol, and gut health:
 👉 https://www.rootremedyic.com/guides
👉 https://www.rootremedyic.com/foundations

Explore More: Find all links, resources, and ways to connect:
 👉 https://linktr.ee/rootremedyic

Transcript

Why These Myths Persist

Speaker 0:01

Last week we talked about science behind what your hormones are actually doing. If you have not listened to part one yet, I would start there because this episode builds on that. Today we are going to move into the part of the conversation that tends to be generating the most confusion, the most fear, and the most conflicting advice for women. What do you actually do about it is what we're going to be addressing today. We are covering four more myths. These are the ones that shape the decisions women make about their own health care, often based on incomplete or outdated information. The goal today is to replace that with real answers. Welcome back to HealthSpan on Her Terms. I'm Dr. Sheri Erwin. I'm an integrative nurse practitioner specializing in women's health, hormones, and functional medicine. This is part two of our hormone myth series. Today we're going to talk about decisions, the timing, and the clinical realities that the standard conversation around women's hormones tends to get wrong. Everything I share on this podcast is for general educational purposes only. It is not meant to be medical advice or meant to create a provider-patient relationship. I am a licensed clinician in specific states, and I'm not a provider that can see everybody. Therefore, you need to take this information back to your own provider that you've established a relationship with.

Is Hormone Therapy Really Dangerous

Speaker 2:38

Hormone therapy is dangerous. This is the myth with the longest shadow. And to understand why it persists, you need to understand where it actually came from. In 2002, the Women's Health Initiative published findings from a large hormone therapy trial that were widely reported as showing that hormone therapy caused breast cancer and heart disease. The headlines were alarming and they weren't everywhere. Prescriptions dropped overnight. An entire generation of providers stopped offering hormone therapy, and an entire generation of women stopped asking for it. That fear has shaped women's health care for over 20 years, and the evidence does not support it. The Women's Health Initiative, also known as WHI, the WHI study had significant design limitations that were not communicated in the original reporting. The average age of participants was sixty-three, meaning most were more than a decade past menopause. The study used oral conjugated equine estrogen combined with synthetic progestin, which is not the same as bioidentical hormone therapy. And the absolute risk increase for breast cancer in the combined arm was small and has been further questioned by subsequent analysis. What the research actually shows is more nuanced and in many respects more reassuring. For women who begin hormone therapy within 10 years of menopause onset or before the age of 60, the evidence supports cardiovascular benefit, not risk. This is called the timing hypothesis or the window of opportunity, and it has been replicated across multiple clinical studies. Estradiol delivered transdermally, meaning through your skin rather than orally, does not appear to carry the same clot risk that oral estrogen does. The route of delivery does matter. Progesterone, the bioidentical form, has a different safety and tolerability profile than the synthetic progestin. The distinction matters clinically, and it is frequently lost in the general conversation about hormone therapy. The risk picture also changes depending on a woman's individual history, her cardiovascular risk factors, her breast cancer risk, and when in her transition she begins. This is why the conversation requires an individualized clinical evaluation and not a blanket policy based on 2002 data. Why this matters for your health span? Women who avoid hormone therapy based on outdated fear may be foregoing one of the most evidence-based supported interventions available for bone density, cardiovascular protection, cognitive function, and quality of life in the transitional years. That is a health span decision and it deserves current information. The question you should be bringing is given my individual history and risk profile, what does the current evidence say about the risk benefit balance for me in particular? The

Perimenopause Signs You Can Miss

Speaker 6:35

sixth myth. You will know when you are in perimenopause. The picture most women have of perimenopause is hot flashes in ilregular menstrual cycles. So they wait for those. And in the meantime, they spend months or years attributing clusters of symptoms to stress, poor sleep habits, anxiety, or just not taking care of themselves well enough. Perimenopause can begin in the late 30s. It doesn't always begin with hot flashes. The earliest signs are often neurological and mood related. They frequently go unrecognized because nobody connects them to hormonal changes. The earliest perimenopausal symptoms that are most commonly missed include new or worsening anxiety, particularly in women who have not historically struggled with anxiety, sleep disruptions, especially those waking between 2 and 4 a.m. I see this quite frequently in my own clinic. I see this when I interject into Facebook groups. It's a very common complaint among women, perimenopausal and menopausal, about this disrupted sleep, but often it's very descriptive, waking up between 2 and 4 a.m. Mood instability that feels different from typical stress response, brain fog and reduced cognitive sharpness. This is another major complaint that I see in clinic. And once again, on a lot of the Facebook and other groups I participate in, brain fog is a major issue for women. It is a life-altering in their personal and professional lives. Cycle changes including shorter cycles, heavier flow, or spotting. Reduced exercise tolerance or slower recovery. Women who used to go to the gym four or five times a week and just boom, bounce back are saying, Man, it's taking me days to recover sometimes from my exercise when it didn't used to be that way. Joint achiness that appears without a clear cause. Once again, women who said, I'm 38 years old, I never had an achy joint, and now all of a sudden I feel like I get out of bed and I'm just so stiff and achy. Once again, these are signs of perimenopause developing. Hot flashes do eventually appear for most women, but they can arrive years into the transition. Waiting for them as a signal means missing the early window when intervention can be most effective. So pay attention to some of those early signs I just mentioned. There is also a laboratory reality worth understanding. In early perimenopause, FSH and estrogy levels can look completely normal on a single blood draw because hormone production is fluctuating rather than consistently declining. A normal lab in this period does not rule out perimenopause. Symptoms and clinical history matter more than a single data point. The average age of menopause in the United States is 51. That means perimenopause, which can last four to 10 years, often begins in the early to mid-40s. For some women, it begins earlier. Like I said, some can have it in their late 30s. Knowing that timeline helps you recognize what you might be experiencing before a provider names it for you. So why does this matter in health span? Early recognition of perimenopause means earlier opportunity to address sleep problems, support your nervous system, evaluate your hormone levels in context with those symptoms, and make informed decisions about the transition. The women who navigate perimenopause best are almost always the ones who understand what was happening and had a clinician willing to work with them through it proactively. Let's

Menopause Is Not The Finish Line

Speaker 10:54

take a look at myth seven. Once you're through menopause, the hormone conversation is over. Menopause is often treated as a finish line. You made it through. Now you adjust to the new normal and move on. I wish it was like that. This framey misses what is arguably the most important window in women's long-term health. The years immediately following menopause are one of the highest yield periods of protecting your bones, cardiovascular health, metabolic function, and your cognitive reserves. What happens in that window and what does not happen shapes health outcomes for decades to come. The hormone conversation does not end at menopause. In many ways, it becomes more consequential. Here is the biology. Estrogen is a protective element for bones, the cardiovascular system, and the brain. When estrogen declines at menopause, that protection changes. Bone loss accelerates in the first several years after menopause. Cardiovascular risk in women rises after menopause and eventually exceeds men's by some measure. Cognitive changes, including early indicators that may relate to long-term risks, are being studied in the context of estrogen transition. Note that this means every woman needs hormone therapy indefinitely. It means the postmenopausal years deserve active clinical attention and ongoing conversation, not a closing of the file because you've reached the finish line. This also applies to things beyond hormone therapy, resistance training for bone and muscle preservation, protein adequacy for muscle maintenance, sleep quality for metabolic and cognitive health, cardiovascular risk monitoring. These are all active health span strategies in the postmenopausal years, not things to defer. Women who feel well in their 60s and 70s and beyond are almost universally women who made deliberate decisions in the decades around their menopause. The window of time matters. So why does this matter again in your health span? If health span is the goal, the postmenopausal years are not a window. They are a critical investment period. The decisions made in this window compound over time in both directions. Active engagement with your health in this period is one of the highest returns women can have.

When Lifestyle Stops Working

Speaker 13:55

Myth eight, eating well and exercising should be enough. I so wish that was true. This one is delicate because the answer is sometimes yes and sometimes genuinely no. And women deserve honesty about which situation they are in. The myth is not that lifestyle matters. It does. It does profoundly. The myth is that lifestyle is always sufficient, and that if it is not working, the problem is effort or consistency. For women, navigating the hormone transition, the physiology has shifted in ways that lifestyle alone doesn't fully address. This is not a failure of discipline. It is biology, and it reserves a clinical response rather than a recommendation to try to just try harder. Here's what changes physiologically that lifestyle cannot fully compensate for. Estrogen decline reduces insulin sensitivity. Women who ate the same way for years may see blood sugar patterns change without changing their diet. Progesterone decline disrupts sleep architecture. Sleep hygiene practices that worked before may become insufficient now. Muscle synthesis becomes less efficient with age and hormonal changes. Protein needs increase. The same workout produces less return on investment. The thyroid function can shift often subtly in ways that change metabolism, energy, and body composition regardless of caloric intake. Cortisol rhythm changes with hormonal transition and with chronic stress, affecting fat distribution and recovery. None of these mean abandoning lifestyle as a foundation. It is still the foundation, but it means that when lifestyle is not producing the results it used to, the question is not what is wrong with your effort. The question is what has changed physiologically and what clinical support would actually address it. Women who are eating well, exercising consistently, sleeping reasonably, and still feel off deserve a clinical evaluation, not another wellness protocol layered on top. Why this matters in your health span? The women who feel best in midlife and beyond are almost never the ones who white knuckled their way through lifestyle alone when the physiology needed clinical support. They are the ones who had honest conversations with their providers who understood the whole picture. Lifestyle and clinical care are not in competition. They are partners.

The Four Myths In One View

Speaker 17:00

Those are the final four myths. That hormone therapy is dangerous based on 2002 data, that you will know when perimenopause starts, that conversation ends with menopause, and that lifestyle alone is always the answer. Hopefully you understood those myths. You came across this episode, and now we're crossing in to another territory. Across both episodes, we looked at these eight myths. Women have been given incomplete stories about their own hormones for years, and that incomplete story has real consequences for how they feel and how they age. Health span is not about living longer while feeling worse. It is about feeling well and functioning well for as long as possible. Hormones are central to that in every decade. And the more clearly you understand what is happening and what your options are, the better equipped you are to advocate for yourself and make decisions that serve you.

Share The Show And Send Questions

Speaker 18:13

If you found this episode useful, please share it with another woman who is navigating these same concerns and not getting real answers. Leave a review if you're able. It helps more women find this podcast. And if there are specific questions you want addressed in future episodes, I want to hear from you. This podcast exists for women who deserve better information. Your questions shape what we cover. I'm Dr. Sheri. Take one small respectful step for your body this week, and I will talk to you next time.